Blood-brain barrier (BBB), a unique membrane barrier formed by closely stitched brain capillary endothelial cells (BCEC) with tight cellular junctions, separates brain from the circulating blood to protect it from bloodborne pathogens. BBB greatly limits the entry of chemotherapeutics to brain, and in consequence, it is a major obstacle for treating brain tumor. Advances in designing efficient nano-drug carriers are opening new avenues for overcoming this uphill systemic challenge. This book chapter describes current understanding of nanocarriers-mediated noninvasive drug targeting to brain tumor. Design principles behind the construction of the most promising recently designed receptor and transporter selective nano-drug carriers for comba...
Therapies directed toward the central nervous system remain difficult to translate into improved cli...
Brain tumors are responsible for almost 2% of deaths in the Western world. The most used methods now...
Introduction: The development of therapeutics for central nervous system (CNS) disorders is still co...
Introduction and purpose: Blood-brain barrier (BBB) consists of capillary endothelium, in which the...
Introduction and purpose: Blood-brain barrier (BBB) consists of capillary endothelium, in which the...
Introduction and purpose: Blood-brain barrier (BBB) consists of capillary endothelium, in which the...
Our brain is protected by physio-biological barriers. The blood–brain barrier (BBB) main mechanism o...
Introduction: Entry of blood circulating agents into the brain is highly selectively controlled by s...
The blood-brain barrier (BBB) is a neurobiological frontier that isolates brain tissues from the blo...
""Nanotechnology-based drug delivery was born as a chance for pharmaceutical weapons to be delivered...
peer-reviewedThe full text of this article will not be available in ULIR until the embargo expires o...
Nanotechnology-based drug delivery was born as a chance for pharmaceutical weapons to be delivered i...
The blood–brain barrier (BBB) is a highly regulated and efficient barrier that provides a sanctuary ...
Nanotechnology-based drug delivery was born as a chance for pharmaceutical weapons to be delivered i...
Introduction: Desired clinical outcome of pharmacotherapy of brain diseases largely depends upon the...
Therapies directed toward the central nervous system remain difficult to translate into improved cli...
Brain tumors are responsible for almost 2% of deaths in the Western world. The most used methods now...
Introduction: The development of therapeutics for central nervous system (CNS) disorders is still co...
Introduction and purpose: Blood-brain barrier (BBB) consists of capillary endothelium, in which the...
Introduction and purpose: Blood-brain barrier (BBB) consists of capillary endothelium, in which the...
Introduction and purpose: Blood-brain barrier (BBB) consists of capillary endothelium, in which the...
Our brain is protected by physio-biological barriers. The blood–brain barrier (BBB) main mechanism o...
Introduction: Entry of blood circulating agents into the brain is highly selectively controlled by s...
The blood-brain barrier (BBB) is a neurobiological frontier that isolates brain tissues from the blo...
""Nanotechnology-based drug delivery was born as a chance for pharmaceutical weapons to be delivered...
peer-reviewedThe full text of this article will not be available in ULIR until the embargo expires o...
Nanotechnology-based drug delivery was born as a chance for pharmaceutical weapons to be delivered i...
The blood–brain barrier (BBB) is a highly regulated and efficient barrier that provides a sanctuary ...
Nanotechnology-based drug delivery was born as a chance for pharmaceutical weapons to be delivered i...
Introduction: Desired clinical outcome of pharmacotherapy of brain diseases largely depends upon the...
Therapies directed toward the central nervous system remain difficult to translate into improved cli...
Brain tumors are responsible for almost 2% of deaths in the Western world. The most used methods now...
Introduction: The development of therapeutics for central nervous system (CNS) disorders is still co...